Elekta CEO to step down as company seeks new leadership

SWEDEN – Elekta’s President and CEO, Gustaf Salford, will step down after the company’s board decided it was time for new leadership.

The Swedish company, known for its precision radiation therapy devices and software, announced the leadership change following disappointing Q3 interim results.

Board Chair and Co-founder Larry Leksell acknowledged the company’s order growth, strong cash flow, and cost control but emphasized the need for a leader who can boost profitability and drive growth.

“Elekta now needs a new leadership that can further intensify the focus on improving profitability and strengthen growth by leveraging the most competitive and advanced offering in the industry,” Leksell stated.

Salford, who joined Elekta 16 years ago and became CEO in 2020, led the company through the COVID-19 pandemic, expanded into new markets, and accelerated innovation programs.

“I would like to thank Gustaf for everything he has contributed,” Leksell said. “As we look forward towards our next chapter, we have agreed to go separate ways, and we wish him the best of luck.”

Salford expressed confidence in Elekta’s future, saying, “I am convinced that Elekta will continue to provide hope for everyone dealing with cancer.”

Jonas Bolander, EVP, General Counsel, and Head of Group Functions, will serve as acting CEO after Salford’s departure on March 6. The board has begun an international search for a permanent replacement.

Elekta reported 621 million SEK (US $58.21 million) in profit from 12.86 billion SEK (US $1.21 billion) in revenue for the nine months ending January 31, 2025. This reflects a 30% drop in profit and a 2% decline in revenue year-over-year.

Despite the challenges, Elekta remains a key player in radiation therapy technology, ranking 56th in annual revenue in the latest Medtech Big 100 report.